STUDY OF HYDROXYUREA MECHANISMS OF ACTION ON LEUKOCYTE ACTIVATION IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE SYNDROMES.
Phase of Trial: Phase IV
Latest Information Update: 20 Jul 2013
At a glance
- Drugs Hydroxycarbamide (Primary)
- Indications Myeloproliferative disorders
- Focus Pharmacodynamics
- 06 Jun 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 15 Jun 2011 New trial record